Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells. by Toran Sanli, Katja Linher-Melville, Theodoros Tsakiridis, Gurmit Singh

Get full text

The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada by Craig A. Beers, Craig A. Beers, Gregory R. Pond, James R. Wright, James R. Wright, Theodoros Tsakiridis, Theodoros Tsakiridis, Gordon S. Okawara, Gordon S. Okawara, Anand Swaminath, Anand Swaminath

Get full text

The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration by Linda A. Villani, Brennan K. Smith, Katarina Marcinko, Rebecca J. Ford, Lindsay A. Broadfield, Alex E. Green, Vanessa P. Houde, Paola Muti, Theodoros Tsakiridis, Gregory R. Steinberg

Get full text

18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer by Aruz Mesci, Elham Ahmadi, Amr Ali, Mohammad Gouran-Savadkoohi, Evangelia Evelyn Tsakiridis, Olga-Demetra Biziotis, Tom Chow, Anil Kapoor, Monalisa Sur, Gregory R. Steinberg, Stanley Liu, Katherine Zukotynski, Theodoros Tsakiridis

Get full text

AMPK β1 reduces tumor progression and improves survival in p53 null mice by Vanessa P. Houde, Sara Donzelli, Andrea Sacconi, Sandra Galic, Joanne A. Hammill, Jonathan L. Bramson, Robert A. Foster, Theodoros Tsakiridis, Bruce E. Kemp, Giuseppe Grasso, Giovanni Blandino, Paola Muti, Gregory R. Steinberg

Get full text

Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance by Elham Ahmadi, Simon Wang, Mohammad Gouran-Savadkoohi, Georgia Douvi, Naghmeh Isfahanian, Nicole Tsakiridis, Brent E. Faught, Jean-Claude Cutz, Monalisa Sur, Satish Chawla, Gregory R. Pond, Gregory R. Steinberg, Ian Brown, Theodoros Tsakiridis

Get full text

Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses by Evangelia E. Tsakiridis, Lindsay Broadfield, Katarina Marcinko, Olga-Demetra Biziotis, Amr Ali, Bassem Mekhaeil, Elham Ahmadi, Kanwaldeep Singh, Aruz Mesci, Panayiotis G. Zacharidis, Alexander E. Anagnostopoulos, Tobias Berg, Paola Muti, Gregory R. Steinberg, Theodoros Tsakiridis

Get full text

The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy by Amr Ali, Bassem Mekhaeil, Olga-Demetra Biziotis, Evangelia E. Tsakiridis, Elham Ahmadi, Jianhan Wu, Simon Wang, Kanwaldeep Singh, Gabe Menjolian, Thomas Farrell, Aruz Mesci, Stanley Liu, Tobias Berg, Jonathan L. Bramson, Gregory R. Steinberg, Theodoros Tsakiridis

Get full text

Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α by Olga‐Demetra Biziotis, Evangelia Evelyn Tsakiridis, Amr Ali, Elham Ahmadi, Jianhan Wu, Simon Wang, Bassem Mekhaeil, Kanwaldeep Singh, Gabe Menjolian, Thomas Farrell, Bassam Abdulkarim, Ranjan K. Sur, Aruz Mesci, Peter Ellis, Tobias Berg, Jonathan L Bramson, Paola Muti, Gregory R Steinberg, Theodoros Tsakiridis

Get full text

Metformin-induced reductions in tumor growth involves modulation of the gut microbiome by Lindsay A. Broadfield, Amna Saigal, Jake C. Szamosi, Joanne A. Hammill, Ksenia Bezverbnaya, Dongdong Wang, Jaya Gautam, Evangelia E. Tsakiridis, Fiorella Di Pastena, Jamie McNicol, Jianhan Wu, Saad Syed, James S.V. Lally, Amogelang R. Raphenya, Marie-Jose Blouin, Michael Pollak, Andrea Sacconi, Giovanni Blandino, Andrew G. McArthur, Jonathan D. Schertzer, Michael G. Surette, Stephen M. Collins, Jonathan L. Bramson, Paola Muti, Theodoros Tsakiridis, Gregory R. Steinberg

Get full text